Research shows that Niacin limits Alzheimer’s Disease progression in lab disease models.

Science Daily writes that recent research published by Indiana University School of Medicine “found that Niacin limits Alzheimer’s disease progression when used in models in the lab, a discovery that could potentially pave the way toward therapeutic approaches to the disease.”

Click here for the full story.

Related Articles